Croatia 2025

Dubrovnik, June 28th – 29th 2025

About the Symposium

The International Neuroimaging Symposium will be held from June 28 to 29, 2025 in the beautiful city of Dubrovnik, Croatia. This prestigious event will showcase the latest advancements in neuroradiology, featuring presentations by eminent lecturers from leading medical academic centers. It offers a unique platform for scientific innovation and the exchange of expertise among professionals in the field.

Agenda

June 28th ⎯ Saturday

Full Day Lectures
Hall at University of Dubrovnik (Rectorate)

Welcome Cocktail Dinner
Sponza Palace

June 29th ⎯ Sunday

Full Day Lectures
Hall at University of Dubrovnik (Rectorate)

Farewell Gala Dinner
Museum of Modern Art Dubrovnik

Call for Abstracts

Submission deadline ⎯ May 1st 2025

We are accepting case reports, educational and scientific submissions, which will be presented in poster format on Sunday, June 29th 2025, from 8:00-9:00AM.

Symposium Committee

Ana M. Franceschi, M.D., Ph.D.
Mario Bekić, M.D., Ph.D.
Bruno Policeni, M.D., MBA
Vilma Kosović, M.D., Ph.D.
David Ozretić, M.D., Ph.D.

Speakers

Neuroradiology experts from the world's most eminent academic centers

Aboian Edouard

(Yale School of Medicine)

Mariam Aboian

Perelman School of Medicine at the University of Pennsylvania - Children's Hospital of Philadelphia

Jennifer Becker

Emory University School of Medicine

Tammie Benzinger

Mallinckrodt Institute of Radiology - Washington University School of Medicine

Maria Borja

University of Miami Leonard M. Miller School of Medicine

Moderators

Alessandro Bozzao

University of Rome La Sapienza Faculty of Pharmacy and Medicine

Krešimir Dolić

University of Split School of Medicine

Fatterpekar Girish

New York University Grossman School of Medicine

Franceschi Maja

Stony Brook University Renaissance School of Medicine

Marko Jakovljević

Perelman School of Medicine at the University of Pennsylvania - Children's Hospital of Philadelphia

Program

TimeSaturday 6-28-2025
  
8:45-9:00WELCOME
  
MODERATORJason Johnson & Nicolaus Mussmacher
9:00-9:15Michael Zeineh (Stanford) – 7T MRI in Neuroradiology
9:15-9:30Maria Ponisio (Wash-U) – Pediatric PET/MRI in Epilepsy
9:30-9:45Haris Sair (Johns Hopkins) – Hierarchical Representation of Functional Connectivity Networks in MRI Using Deep Learning
9:45-10:00Damien Galanaud (Sorbonne) – Monitoring Neurogenetic Diseases Evolution with DTI
10:00-10:15Chris Whitlow (Wake Forest) – Advanced Neuroimaging for TBI
10:15-10:30Salil Soman (Harvard) – Advanced Susceptibility Neuroimaging
  
10:30-11:00Coffee Break
  
MODERATORKrešimir Dolić & Girish Fatterpekar
11:00-11:15Sonja Blum (Cornell) – Alzheimer’s Disease Diagnostic Criteria: The Role of the Neuroradiologist
11:15-11:30Tammie Benzinger (Wash-U) – Dementia PET/MR Imaging
11:30-11:45Dinko Franceschi (SBU) – FDG Beyond Alzheimer & FTD: It’s Never Too LATE
11:24-12:00Ana Franceschi (Northwell) – ARIA in the Era of Disease-modifying Therapies
12:00-12:15Jean-Pierre Pruvo (Lille) – Imaging of Mental Health
12:15-12:30Jeremy Ford (Harvard) – Glymphatic Imaging
  
12:30-13:30Lunch
  
MODERATORBruno Policeni & Maja Marinović Guić
13:30-13:45Claudia Kirsch (Yale) – Leveraging UHF MRI and AI to Assess Head and Neck Pathology
13:45-14:00Hilda Stambuk (MSKCC) – Larynx: Anatomy and Pathways of Tumor Spread
14:00-14:15Snehal Patel (MSKCC) – The Cutting Edge: Leveraging in vivo Imaging, 3D Modeling and AI for Precision Head and Neck Cancer Surgery
14:15-14:30Bruno Policeni (U-Iowa) – Photon Counting CT: Clinical Applications in Head and Neck
14:30-14:45Amy Juliano (Harvard) – Sensorineural Hearing Loss: Not the Usual Suspects
14:45-15:00Carlos Zamora (UNC) – Skull base lesions: The Good, the Bad, and the Pretenders
  
15:00-15:30Coffee Break
  
MODERATORClaudia Kirsch & Marko Jakovljević
15:30-15:45Amish Doshi (Mount Sinai) – AI Triage in Brain and Spine: Current Applications
15:45-16:00Jennifer Becker (Emory) – DTI in the Spinal Cord
16:00-16:15Karen Salzman (Utah) – Spinal Cord Tumors
16:15-16:30Wende Gibbs (Barrow) – Degenerative Spine
16:30-16:45Maria Gisele Matheus (MUSC) – Non-traumatic Spine Emergencies
16:45-17:00Maria Borja (University of Miami) – Spine Webs, Cysts and Cord Herniations
Time Sunday 6-29-2025
   
8:00-9:00 POSTER SESSION
   
MODERATOR Christopher Whitlow & Ljiljana Marčić
9:00-9:12 Rajan Jain (NYU) – Brain Tumor Perfusion and Radiogenomics
9:12-9:24 Robert Young (MSKCC) – Comprehensive Imaging of Low-Grade Gliomas
9:24-9:36 Jason Johnson (Yale) – Dual-point FDG for Brain Tumors
9:36-9:48 Mariam Aboian (U-Penn) – Translating Brain Tumor Advances to Clinical Practice
9:48-10:00 Harpreet Hyare (UCL) – Proton Beam Therapy: Challenges and Considerations
10:00-10:12 Alessandro Bozzao (Rome Sapienza) – ASL Perfusion MRI for Tumor Diagnosis and Follow-up
   
10:25-11:00 Coffee Break
   
MODERATOR Alessandro Bozzao & Vilma Kosović
11:00-11:12 Nadya Pyatigorskaya (Sorbonne) – HIFU in Neuroradiology: MRI-Guided Precision Therapy for the Brain
11:12-11:24 Girish Fatterpekar (NYU) – State-of-the-Art GRASP Permeability Imaging of the Pituitary Gland
11:24-11:36 Lotfi Hacein-Bey (UC Davis) – Imaging Workup of Stroke: What Have We Learned
11:36-11:48 Edouard Aboian (Yale) – Cerebrovascular Anatomic Considerations in Operative Management of Symptomatic Carotid Disease
11:48-12:00 Maria Vittoria Spampinato (MUSC) – Neurovascular Applications of Photon-Counting CT
12:00-12:12 Richard Benzinger (Wash-U) – Role of Anesthesia in Clinical Neuroimaging
   
12:25-13:30 Lunch
   
MODERATOR Maja Franceschi & David Ozretić
13:30-13:42 Ali Nabavizadeh (U-Penn) – Pediatric Brain Tumors: Precision Imaging
13:42-13:54 Christopher Filippi (University of Toronto) – Neonatal MR Imaging
13:54-14:06 Ivana Pogledić (Vienna) – Prenatal Assessment of Brain Malformations
14:06-14:18 Luc van den Hauwe (Antwerp) – Chiari Deformities
14:18-14:30 Brent Weinberg (Emory) – Spontaneous Intracranial Hypotension & CSF Leaks
14:30-14:42 Amit Mahajan (Yale) – CNS Infections: Imaging Appearances
   
15:00-15:30 Coffee Break
   
MODERATOR Luc van den Hauwe & Sanja Lovrić Kojundžić
15:30-15:42 Gaurang Shah (Ann Arbor) – Imaging of Orbits and Optic Nerves
15:42-15:54 Vadim Grechushkin (NYU) – Orbital Emergencies
15:54-16:06 Roy Riascos (UTHealth McGovern) – Imaging of Cranio-Cervical Junction Trauma
16:06-16:18 James Provenzale (Duke) – MRI Artifacts You Need to Recognize
16:18-16:30 Leo Wolansky (U-Conn) – Gadolinium Safety & Gadopiclenol
16:30-16:42 Dawn Behr-Ventura (Nortwell) – Radiology Reporting: Templates and Workflows

Symposium Venue

University of Dubrovnik, Ul. branitelja Dubrovnika 29, 20000, Dubrovnik

Special thanks to our Sponsors

Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer’s disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on FacebookInstagram and LinkedIn. P-LLY

At Siemens Healthineers, we pioneer breakthroughs in healthcare. For everyone. Everywhere.
Sustainably. As a leader in medical technology, we want to advance a world in which breakthroughs
in healthcare create new possibilities with a minimal impact on our planet. By consistently bringing
innovations to the market, we enable healthcare professionals to innovate personalized care, achieve
operational excellence, and transform the system of care.
Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is
crucial for clinical decision-making and treatment pathways. With the unique combination of our
strengths in patient twinning (1) , precision therapy, as well as digital, data, and artificial intelligence
(AI), we are well positioned to take on the greatest challenges in healthcare. We will continue to
build on these strengths to help overcome the world’s most threatening diseases, enable efficient
operations, and expand access to care.
We are a team of 73,000 Healthineers in over 70 countries passionately pushing the boundaries of
what is possible in healthcare to help improve the lives of people around the world.

 


*1 Personalization of diagnosis, therapy selection and monitoring, aftercare, and managing health.

Cortechs.ai develops and markets cutting-edge imaging solutions that are used by radiologists, neurologists, and oncologists in hundreds of clinics and research centers around the world. The Cortechs.ai team includes scientists, engineers, business professionals, and clinical specialists working towards the common goal of improving the diagnosis and treatment of patients with neurodegenerative disorders and cancers.

Cortechs.ai’s flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician’s desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer’s disease, multiple sclerosis, epilepsy and traumatic brain injury. 

For more information: www.cortechs.ai

Gleamer, a leader in the development of Artificial Intelligence solutions for medical imaging, aims to establish AI as a key solution to meet the rapidly growing demand in medical imaging. The Gleamer Copilot® is deployed in over 2,000 public and private institutions across 40 countries, processing more than 30 million exams annually. It incorporates several proprietary AI solutions designed to support radiologists, enhancing patient care, reducing healthcare costs, accelerating patient treatment, and optimizing workflow and productivity. Its excellence and performance are globally recognized, with 30 publications in prestigious peer-reviewed scientific journals with expert radiologists, including the Alexander Margulis 2022 award for the best paper in the journal “Radiology”, awarded for scientific excellence by the Radiological Society of North America (RSNA).

Founded in 2017 and based in Paris, France, Gleamer currently employs 80 collaborators.

For more information: www.gleamer.ai/

Founded in 2011, icometrix (Leuven, Belgium | Boston, MA, USA) strives for data-driven insights and personalized patient care, supported by AI. icometrix offers a portfolio of eight regulatory approved AI solutions to assist healthcare with various challenges; icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer’s disease. icompanion, a digital platform, and mobile app helps people with MS and their care team to monitor clinical symptoms and treatments efficiently and objectively. Today, icometrix is internationally active and integrated into more than 330 clinical sites. In addition, icometrix supports pharmaceutical companies in phase I-III trials as well as in Real-World Evidence (RWE) studies through imaging and data services, and digital health strategy.

For more information: www.icometrix.com/

DocPanel is an AI enabled radiology platform acting as the conduit for subspecialty radiology interpretations. Established in 2016, DocPanel is connected to over 10,000 imaging sites, connecting them to a network of over 1,000 subspecialty radiologists. Leading Hospitals and Academic Medical Centers across the US rely on DocPanel to onboard subspecialty radiologists for dedicated daily coverage to keep their turnaround times down.

For more information: docpanel.com

Contact

Promo Event Agency Promotion & Events d.o.o.
Smiljanićeva 2, 21000 Split, Croatia

ins2025@promoevent.hr